The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics
Abstract
Objective: The European Registry on Cushing's syndrome (ERCUSYN) is designed to collect prospective and follow-up data at EU level on Cushing's syndrome (CS). Design and methods: Baseline data on 481 CS patients (390 females, 91 males; mean age (± s.d. ): 44±14 years) collected from 36 centres in 23 countries, including new patients from 2008 and retrospective cases since 2000. Patients were divided into four major aetiologic groups: pituitary-dependent CS (PIT-CS) (66%), adrenal-dependent CS (ADR-CS) (27%), CS from an ectopic source (ECT-CS) (5%) and CS from other aetiologies (2%). Results: Proportion of men in the ECT-CS group was higher than in the other groups ( P <0.05). The ADR-CS group was older than the PIT-CS ( P <0.05). Prevalence of hirsutism (92%) and diabetes (74%) in ECT-CS was higher than in the other groups ( P <0.05 and P <0.01 respectively). PIT-CS had more skin alterations, menstrual irregularities and hirsutism than ADR-CS ( P <0.01). Reduced libido was more prevalent in men than women ( P <0.01). Prevalence of spine osteoporosis was higher in men than women ( P <0.05), and males had more vertebral and rib fractures than females (52 vs 18% for vertebrae; P <0.001 and 34 vs 23% for ribs; P <0.05). ECT-CS consulted a diabetologist more frequently than ADR-CS ( P <0.05), while a gynaecologist was consulted more often by women with PIT-CS or ADR-CS than with ECT-CS ( P <0.05). Overall, weight gain was more common in women than men ( P <0.01). CushingQoL and EuroQoL visual analogue scale scores did not differ between the groups. Conclusions: The ERCUSYN project demonstrates a heterogeneous clinical presentation of CS at a European level, depending on gender and aetiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From % to % of patients with endogenous CS have DM, and % to % have defective glucose tolerance, so the overall prevalence of glucose metabolism impairments can come close to %, as shown in Table (, , -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [187]
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationNewell-Price, J. D. C., BERTAGNA, X. Y., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,258
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Self-citationIncidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt‐Rasmussen, U., Hagen, C., Jørgensen, J. O. L., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 763
Ilias, Ι., Torpy, D. J., Pacák, K., Mullen, N., WESLEY, R. A., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2527 · Cited by 714
Orth, D. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321207 · Cited by 563
Isidori, A. M., Kaltsas, G., Pozza, C., Frajese, V., Newell-Price, J. D. C., Reznek, R. H., Jenkins, P. J., Monson, J. P., Grossman, A. B., & BESSER, G. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1542 · Cited by 525
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 505
Research works printed but not linked: 2
- 2004, 34, 593
- 2000, Medical care, 47, 255
Cited by
Sorted by citations
Items 201–300 of 402
Glucocorticoid-induced myopathy: a comprehensive review
Géfard-Gontier, E., Quang, M. L., Martin‐Négrier, M., Violleau, M., Solé, G., & Mathis, S. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13482-6 · Cited by 8
Effets indésirables métaboliques et cardiovasculaires des corticothérapies systémiques
Fardet, L. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.12.005 · Cited by 8
Differences in skin lesions of endogenous and exogenous Cushing’s patients
Erden, F., Borlu, M., Şimşek, Y., & Keleştemur, H. (2018) · Advances in Dermatology and Allergology · doi:10.5114/ada.2018.74639 · Cited by 8
Long-term outcome of trans-sphenoidal surgery for Cushing’s disease in Indian patients
Saini, S., Kanwar, J., Gupta, S. K., Behari, S., Bhatia, E., & Yadav, S. (2018) · Acta Neurochirurgica · doi:10.1007/s00701-018-3736-0 · Cited by 8
Investigating hypertension in younger patients
Rison, S. C. G., Carvalho, C., Rull, G., & Robson, J. P. (2022) · BMJ · doi:10.1136/bmj-2021-067924 · Cited by 8
Corticotroph tumor progression after bilateral adrenalectomy: data from ERCUSYN
Valassi, E., Castinetti, F., Ferrière, A., Tsagarakis, S., Feelders, R. A., Netea-Maier, R. T., Droste, M., Strasburger, C. J., Maiter, D. M., Kaštelan, D., et al. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0074 · Cited by 8
Self-citationCushing’s syndrome in women: age-related differences in etiology and clinical picture
Akirov, A., Dery, L., Fleseriu, M., Rudman, Y., Shimon, I., Manisterski, Y., Aviran-Barak, N., Nadler, V., Alboim, S., Shochat, T., et al. (2022) · Pituitary · doi:10.1007/s11102-022-01292-2 · Cited by 11
Persistent Cushing’s Disease after Transsphenoidal Surgery: Challenges and Solutions
Albani, A., & Theodoropoulou, M. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1220-6056 · Cited by 8
Etiology-, Sex-, and Tumor Size-Based Differences in Adrenocorticotropin-Dependent Cushing Syndrome
Walia, R., Dutta, A., Gupta, N., Bhansali, A. K., Pivonello, R., Ahuja, C. K., Dhandapani, S., Dutta, P. R., Bhadada, S. K., Simeoli, C., et al. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.11.014 · Cited by 8
Webb, S. M., Kristensen, J. K., Vitali, D., van Klink, S., van Beuzekom, C., Vives, A. S., & Nordenström, A. (2021) · Endocrine · doi:10.1007/s12020-021-02625-0 · Cited by 8
Self-citationVoltan, G., Mazzeo, P., Cannito, M., Pinelli, S., Barbot, M., Scaroni, C. M., Ceccato, F., & Camozzi, V. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf008 · Cited by 7
Impact of remission status in endogenous Cushing's syndrome on cancer incidence
Rudman, Y., Fleseriu, M., Masri‐Iraqi, H., Shochat, T., Kushnir, S., Shimon, I., & Akirov, A. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf028 · Cited by 7
Ceccato, F., Terzolo, M., Gatto, F., Cannavò, S., Bianchi, A., Isidori, A. M., Colao, A. A. L., Ferone, D., Aimaretti, G., Giraldi, F. P., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02758-3 · Cited by 10
Cushing's syndrome: Consequences of late diagnosis after bariatric surgery
Pedro, J. M. P., Belo, S., Guerreiro, V. A., Ferreira, M. J., Salazar, D. A., Costa, C. F., Esteves, C., Pereira, J., Freitas, P., & Carvalho, D. M. (2020) · Clinical Case Reports · doi:10.1002/ccr3.2694 · Cited by 6
Bray, D. P., Rindler, R. S., Dawoud, R. A., Boucher, A. B., & Oyesiku, N. M. (2022) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2021.12.006 · Cited by 7
Skeletal fragility in pituitary disease: how can we predict fracture risk?
Bioletto, F., Berton, A. M., Barale, M., Aversa, L. S., Sauro, L., Presti, M., Mocellini, F., Sagone, N., Ghigo, E., Massimo, P., et al. (2024) · Pituitary · doi:10.1007/s11102-024-01447-3 · Cited by 7
Cushing's Syndrome in a Morbidly Obese Patient Undergoing Evaluation before Bariatric Surgery
Borsoi, L., Ludvik, B. H., Prager, G., Luger, A., & Riedl, M. (2014) · Obesity Facts · doi:10.1159/000363260 · Cited by 7
Koracevic, G. P., Stojkovic, M., Lović, D. B., Pavlović, M., Kostić, T. L., Kutlesic, M. S., Mićić, S., Koraćević, M., & Djordjević, M. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666181005122339 · Cited by 7
Serban, A. L., Rosso, L., Mendogni, P., Cremaschi, A., Indirli, R., Mantovani, B., Rumi, M. G., Castellani, M., Chiti, A., Croci, G. A., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.687539 · Cited by 8
Kober, P., Rusetska, N., Mossakowska, B. J., Maksymowicz, M., Pękul, M., Zieliński, G., Styk, A., Kunicki, J., Działach, Ł., Witek, P., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124646 · Cited by 7
Are there Reliable Predictors for the Impaired Quality of Life in Patients With Cushing’s Syndrome?
Nankova, A. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.482 · Cited by 7
Feingold, K. R. (2015) · Europe PMC (PubMed Central) · Cited by 7
How to manage pasireotide, when using as medical treatment for Cushing’s disease
Petersenn, S. (2015) · Endocrine · doi:10.1007/s12020-015-0754-z · Cited by 7
Parksook, W. W., Laichuthai, N., & Sunthornyothin, S. (2020) · Case Reports in Endocrinology · doi:10.1155/2020/2946868 · Cited by 6
Chihaoui, M., Oueslati, I., Khessairi, N., Chaker, F., Cherni, S., Hammami, B., Feki, M., & Yazidi, M. (2023) · Endocrine Regulations · doi:10.2478/enr-2023-0017 · Cited by 6
Stifel, U., Vogel, F., Caratti, G., Reincke, M., & Tuckermann, J. P. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21185 · Cited by 6
Cai, Y., Zhao, X. Y., Ren, L., Liu, S. J., Liu, X., Gang, X., & Wang, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-53913-4 · Cited by 6
Dery, L., Stern, J., Shimon, I., Rudman, Y., Kushnir, S., Shochat, T., Fleseriu, M., & Akirov, A. (2024) · Pituitary · doi:10.1007/s11102-024-01399-8 · Cited by 6
Dhingra, A., Ganie, M. A., Dharmshaktu, P., Chakraborty, S., Jyotsna, V. P., & Gupta, N. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0879-5122 · Cited by 6
de Eulate-Beramendi, S. Á., Ortega, A. C., Ollero, L., Niemann, L. K., Fernandez-Miranda, J. C., Bruneau, M., Berhouma, M., Cavallo, L. M., Cornelius, J. F., Daniel, R. T., et al. (2022) · Brain and Spine · doi:10.1016/j.bas.2022.100917 · Cited by 7
Association of Acne Tarda with Endocrinological Disorders
Makrantonaki, E., & Zouboulis, C. C. (2022) · Dermato · doi:10.3390/dermato2040010 · Cited by 6
Whole blood transcriptomic signature of Cushing's syndrome
Birtolo, M. F., Armignacco, R., Benanteur, N., Baussart, B., Villa, C., Murat, D. D., Guignat, L., Groussin, L., Libé, R., Zennaro, M., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae083 · Cited by 6
A Rare Presentation of Subclinical Cushing's Syndrome as a Pubic Fracture
Arduç, A., Dogan, B. A., Akbaba, G., Duran, İ. D., Küçükler, K., Işık, S., Özuğuz, U., Berker, D. S., & Güler, S. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1489 · Cited by 6
Imaizumi, Y., Ibaraki, A., Asada, S., Tominaga, M., Hayashi, H., Tsuchihashi, T., Eguchi, K., Kario, K., & Taketomi, A. (2016) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000206 · Cited by 6
Rosset, A., Greenman, Y., Osher, E., Stern, N., & Tordjman, K. M. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.02.012 · Cited by 7
Patient reported outcomes and treatment satisfaction in patients with cushing syndrome
Rakovec, M., Zhu, W., Khalafallah, A. M., Salvatori, R., Hamrahian, A. H., Gallia, G. L., Ishii, M., London, N. R., Ramanathan, M., Rowan, N. R., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03214-5 · Cited by 6
Han, M.-M., Cao, X.-M., Liu, Z., Zhang, Y., & Liu, Y. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i3.100580 · Cited by 5
Costello, H. M., Grenier, C., Ivy, J. R., Czopek, A., Jones, N. K., Krilis, G., Stewart, K., Nespoux, J., Holmes, M. C., Livingstone, D. E. W., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.24473 · Cited by 5
Behaviour disorder caused by Cushing's syndrome in an older person.
Damanti, S., Abbate, C., Chiodini, I., Cesari, M., Nestola, T., Belloni, G., Mandelli, C., Mari, D., & Lucchi, T. (2018) · Age and Ageing · doi:10.1093/ageing/afy102 · Cited by 4
Evaluating Patient-Reported Outcomes in Cushing’s Syndrome
Gumaste, N., Shah, L., Cheesman, K. C., & Geer, E. B. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.05.002 · Cited by 5
Pituitary adenomas registry in Thailand
Kwancharoen, R., Deerochanawong, C., Peerapatdit, T., & Salvatori, R. (2023) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2023.07.026 · Cited by 5
Different patient versus provider perspectives on living with Cushing’s disease
Halstrom, A., Lin, I., Lin, A. L., Cohen, M. A., Tabar, V. S., & Geer, E. B. (2024) · Pituitary · doi:10.1007/s11102-024-01381-4 · Cited by 5
The Landscape of Androgens in Cushing’s Syndrome
Nowotny, H. F., Braun, L., & Reisch, N. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2333-1907 · Cited by 5
Syndrome de Cushing : quand y penser ? Comment l’affirmer ?
Guignat, L., & Bertherat, J. Y. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.02.005 · Cited by 5
Buonacera, A., Stancanelli, B., & Malatino, L. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0200-9 · Cited by 5
Warncke, K., Kummer, S., Kann, P. H., Bergis, D., Bollow, E., Hummel, M., Zoicas, F., Wernert, S., & Holl, R. W. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0600-9649 · Cited by 5
Ramírez-Villaescusa, J., Ruiz-Picazo, D., Lamas, C., & Morillas-Ariño, C. (2020) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2020.09.182 · Cited by 5
Improving Quality of Life in Patients with Pituitary Tumours
Crespo, I., Vives, A. S., Resmini, E., Valassi, E., Martínez-Momblán, M.-A., & Webb, S. M. (2014) · US Endocrinology · doi:10.17925/use.2014.10.01.79 · Cited by 5
Self-citationThe Severity of Bone Loss: A Comparison Between Cushing’s Disease and Cushing’s Syndrome
Naguib, R., Elkemary, E., & Elsharkawi, K. M. (2023) · Journal of Endocrinology and Metabolism · doi:10.14740/jem857 · Cited by 5
Metabolic profile differences in ACTH‐dependent and ACTH‐independent Cushing syndrome
Li, Z., Zhang, C., Geng, C., & Song, Y. (2021) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2021.08.004 · Cited by 5
Jurek, A., Krzesiński, P., Uziębło‐Życzkowska, B., Witek, P., Zieliński, G., Kazimierczak, A., Wierzbowski, R., Banak, M., & Gielerak, G. G. (2025) · Scientific Reports · doi:10.1038/s41598-024-84888-x · Cited by 4
Changes in clinical features of adrenal Cushing syndrome: a national registry study
Katabami, T., Asai, S., Matsuba, R., Sone, M., Izawa, S., Ichijo, T., Tsuiki, M., Okamura, S., Yoshimoto, T., Otsuki, M., et al. (2025) · Endocrine Connections · doi:10.1530/ec-24-0684 · Cited by 4
Secondary causes of diabetes: a crossroad of endocrinology and oncology
Hee, N. K. Y., Lim, Q. H., Khunti, K., Ooi, Y., Yen, I., Saad, M. B., Ekinci, E. I., Li, H., Vethakkan, S. R., Chan, J. C. N., et al. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00027-6 · Cited by 4
Lam-Chung, C., & Ramos, D. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075785 · Cited by 4
Atar, R. V. (2020) · Northern Clinics of Istanbul · doi:10.14744/nci.2019.54771 · Cited by 4
Ding, L., Wang, B.-P., Chen, T.-T., Li, P., Guo, W., Fan, Y.-X., Fang, F., Cui, J., Dong, Z.-L., He, Q., et al. (2021) · Pituitary · doi:10.1007/s11102-021-01126-7 · Cited by 2
Association of IGF-1 Level with Low Bone Mass in Young Patients with Cushing’s Disease
Sun, W., Sun, Q., Cui, Q., He, M., Wu, W., Li, Y., Ye, H., & Zhang, S. (2023) · International Journal of Endocrinology · doi:10.1155/2023/3334982 · Cited by 4
Moyers, S. A., & Tiemensma, J. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02480-y · Cited by 5
Nellesen, D., Truong, H. L., Neary, M. P., & Ludlam, W. H. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1135049 · Cited by 4
Trabecular bone score (TBS) in Cushing's disease: TBS gain after hypercortisolism normalization
Tan, E., Guignat, L., Dellal, A., Winzenrieth, R., Cormier, C., & Koumakis, E. (2024) · Bone · doi:10.1016/j.bone.2024.117109 · Cited by 3
Quality of life in patients with pituitary tumors
Webb, S. M., Martínez-Momblán, M.-A., Resmini, E., Valassi, E., & Vives, A. S. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.02.004 · Cited by 3
Self-citationBalsak, B. Ö. T., İmga, N. N., Polat, Ş. B., Aydin, C., Topaloğlu, O., Ersoy, R., & Çakır, B. (2025) · Postgraduate Medicine · doi:10.1080/00325481.2025.2455373 · Cited by 3
Ferraù, F., Alessi, Y., Nista, F., Roux, A., Ferone, D., & Arvat, E. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02537-0 · Cited by 3
Chacko, S. R., Sharma, S. S., Ahmadian, S., Saini, J., Fell, V. M., Peersen, A. F., Atkinson, E. J., Gruber, L., Gompel, J. J. V., Simha, V., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf693 · Cited by 3
Neuroendocrine neoplasia and bone (Review)
Ghemigian, A. M., Carşote, M., Şandru, F., Petca, R., Oproiu, A. M., Petca, A. T., & Valea, A. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10653 · Cited by 3
Hypocalcemia Is a Common Risk Factor for Osteoporosis in Taiwanese Patients with Cushing’s Syndrome
Chen, Y., Tsai, J., Chen, J., & Shen, F. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192316064 · Cited by 4
Seco-Cervera, M., Ibáñez-Cabellos, J. S., Pallardó, F. V., García‐Giménez, J. L., Aulinas, A., Martel‐Duguech, L., Webb, S. M., & Valassi, E. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1410080 · Cited by 3
Self-citationUSP8 Mutations Associated with Cushing’s Disease Alter Protein Structure Dynamics
Petukhova, N. V., Poluzerova, A., Bug, D. S., Nerubenko, E., Kostareva, A. A., Tsoy, U. A., & Dmitrieva, R. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312697 · Cited by 3
Síndrome de Cushing: veinticinco años de experiencia clínica en Navarra
García, L. P., Anda, E., & Rojo, J. (2012) · Anales del Sistema Sanitario de Navarra · doi:10.4321/s1137-66272012000300012 · Cited by 3
Screening for ACTH-dependent hypercortisolism in patients with pituitary incidentaloma
Torpy, D. J. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0058 · Cited by 3
Pan, B., Song, Y. J., Kong, X., Xue, Z., & Guo, Y. (1998) · PubMed · Cited by 3
Cushing Syndrome: Presentation, Diagnosis, and Treatment, Including Subclinical Cushing Syndrome
Neychev, V. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_9 · Cited by 3
Stieg, M. R., Auer, M. K., Berr, C., Fazel, J., Reincke, M., Zopp, S., Yassouridis, A., & Stalla, G. K. (2019) · Pituitary · doi:10.1007/s11102-019-00942-2 · Cited by 3
Hamidi, O., St-Jean, M., Lacroix, A., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag095 · Cited by 5
Sun, Q., Sun, W., Ye, H., & Zhang, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1412046 · Cited by 2
Wolf, P. S., Travers, S., Domenig, O., Baron, S., Blanchard, A., Bouazizi, K., Kachenoura, N., Salenave, S., Poglitsch, M., Redheuil, A. B., et al. (2025) · Endocrine Connections · doi:10.1530/ec-24-0617 · Cited by 2
Self-citationBednarski, F., Braun, L., Vogel, F., Adolf, C., Nowak, E., Zopp, S., Rubinstein, G., Beuschlein, F., Zimmermann, P., Reincke, M., et al. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf226 · Cited by 2
Minasyan, M., Gamrat-Żmuda, A., Bryk-Wiązania, A. H., Suchy, W., Bogusławska, A., Rzepka, E., Piwońska‐Solska, B., Majka, K., Hubalewska–Dydejczyk, A., Valassi, E., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1785054 · Cited by 2
Self-citationCastinetti, F., Bertherat, J. Y., Chanson, P., Raverot, G., Young, J., & Tabarin, A. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10020-1 · Cited by 3
Self-citationSilva, J. M. D. A., de Aguiar, G. B., Conti, M. L. M., dos Santos, A. R. L., Lima, J. V., & Veiga, J. C. E. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003301 · Cited by 2
Self-citationEl año 2011 en Neuroendocrinología
Puig‐Domingo, M., Castano, J. P., Álvarez‐Escolá, C., Resmini, E., Venegas, E., Arnés, J. G., Torres, E., Beatriz Lecumberri, S., Barahona, M. J., Lamas, C., et al. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.01.009 · Cited by 2
Self-citationBone mineral density in patients with Cushing’s syndrome
Seker, A., & Yavuz, D. G. (2024) · Marmara medical journal · doi:10.5472/marumj.1485351 · Cited by 2
Valizadeh, M., Rahmani, F., Nikoohemmat, M., Ahmadi, A. R., Hosseinpanah, F., Niroomand, M., Bagheri, A. K., Grossman, A. B., & Abiri, B. (2024) · Endocrine Research · doi:10.1080/07435800.2024.2381720 · Cited by 2
Medicamental treatment of Itsenko-Cushing’s disease. The current state-of-the art
Mel'nichenko, G. A., Popovich, V., Rozhinskaya, L. Y., & Belaya, Z. E. (2014) · Problems of Endocrinology · doi:10.14341/probl201460629-37 · Cited by 2
Cushing syndrome secondary to a mediastinal carcinoid tumor: a case report
Ershadi, R. E., Vahedi, M., Jahanbin, B., Sarbazzadeh, J., & Rafieian, S. (2022) · International Cancer Conference Journal · doi:10.1007/s13691-022-00542-1 · Cited by 2
Cushing´s syndrome: twenty-five years of clinical experience in Navarre
GarcÃa, L. P., Anda, E., & Rojo, J. (2012) · Anales del Sistema Sanitario de Navarra · doi:10.23938/assn.0102 · Cited by 2
Cushing’s Disease – Quality of Life, Recurrence and Long-term Morbidity
Huguet, I., Ntali, G., Grossman, A. B., & Karavitaki, N. (2015) · US Endocrinology · doi:10.17925/use.2015.11.1.55 · Cited by 2
Kufukihara, R., Takeda, T., Hakozaki, K., Yasumizu, Y., Tanaka, N., Matsumoto, K., Morita, S., Kosaka, T., Mizuno, R., 浅沼, 宏., et al. (2022) · International Journal of Urology · doi:10.1111/iju.15007 · Cited by 2
Ethics in Authorship: Considerations and Concerns
Pinho, I., Pinho, J., & Nery, F. (2022) · Acta Médica Portuguesa · doi:10.20344/amp.18646 · Cited by 2
Commentary on Cushing Syndrome due to Ectopic Acth
Levine, A. C., & Sanchez, J. (2017) · Endocrine Practice · doi:10.4158/ep171941.co · Cited by 2
Assessment of Quality of Life in Patients with Cushing's Syndrome
Erkinovna, E. S., Hudaybetgenovn, S. O., Dzhumaniyazovna, N. G., & qizi, K. Y. A. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s06.308 · Cited by 1
A Challenging Case of Cushing’s Syndrome Due to Ectopic Adrenocorticotropic Hormone Secretion
Irimie, C. A., Irimie, M., & Varciu, M. S. (2023) · Journal of Endocrinology and Metabolism · doi:10.14740/jem889 · Cited by 1
Schoeb, M., Sintenie, P. J. C., Bakker, L. E. H., Biermasz, N. R., van Haalen, F. M., Nijhoff, M. F., de Vries, F., Winter, E. M., Pereira, A. M., & Appelman‐Dijkstra, N. M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae799 · Cited by 1
Androgens differentially modulate glucocorticoid effects on adipose tissue and lean mass
Sommers, V., David, K., Helsen, C., Moermans, K., Stockmans, I., Ferrari, G., Dmitriev, R. I., Stegen, S., Meijer, O. C., Kroon, J., et al. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0061 · Cited by 1
Szklarz, M., Gontarz-Nowak, K., Górny, J. M., & Matuszewski, W. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01994-1 · Cited by 1
Dragunova, N. V., Belaya, Z. E., Sasonova, N. I., Sopodovnikov, A. G., Тамерланович, Ц. Т., Rozhinskaya, L. Y., Hans, D. B., Mel'nichenko, G. A., & Dedov, I. I. (2015) · Problems of Endocrinology · doi:10.14341/probl20156149-16 · Cited by 1
Владимировна, К. И., Dreval', A. V., Чеканова, А. В., & Анатольевна, А. Л. (2016) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2016-44-4-430-438 · Cited by 1
Screening of subclinical Cushing's syndrome in patients with arterial hypertension
Третяк, О. Е., & Черенько, С. М. (2018) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.1(61).2018.126905 · Cited by 1
Tabti, E., Benmekki, A., Bestaoui, M. H., Messaad, M., Ghembaza, A., & Lounici, A. (2018) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2018.05.001 · Cited by 1
Lethielleux, G., & Bertherat, J. Y. (2020) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(20)44310-7 · Cited by 1
Metadata
- Authors
- Valassi, E., Santos, A., Yaneva, M., Tóth, M., Strasburger, C. J., Chanson, P., Wass, J. A. H., Chabre, O., Pfeifer, M., Feelders, R. A., Tsagarakis, S., Trainer, P. J., Franz, H., Zopf, K., Zacharieva, S., Lamberts, S. W. J., Tabarin, A., & Webb, S. M.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- Medical University of Sofia (BG)
- Semmelweis University (HU)
- Charité – Universitätsmedizin Berlin (DE)
- Université Paris-Sud (FR)
- Churchill Hospital (GB)
- Ljubljana University Medical Centre (SI)
- Erasmus MC (NL)
- Polyclinic General Hospital (GR)
- The Christie Hospital (GB)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Corresponding author
- Valassi, Elena
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09
- Volume
- 165
- Issue
- 3
- Pages
- 383-392
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2171877884
- Semantic Scholar
- 3321b1ce595761b981c3e19ea91e6efc18a85c8e
- Cited by
- 402
- References
- 36
- Citations by year
- 2026: 28 · 2025: 25 · 2024: 27 · 2023: 29 · 2022: 44 · 2021: 31 · 2020: 27 · 2019: 24 · 2018: 35 · 2017: 20 · 2016: 23 · 2015: 38 · 2014: 19 · 2013: 15 · 2012: 15
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's syndrome, pituitary-dependent Cushing's disease, ectopic ACTH syndrome, clinical features, sex differences, hirsutism, diabetes mellitus, osteoporosis, quality of life, EuroQol, patient registry
- MeSH terms
- Adolescent, Adrenal Gland Neoplasms, Adult, Aged, Aged, 80 and over, Bone Diseases, Metabolic, Cushing Syndrome, Europe, Female, Humans, Male, Middle Aged, Pituitary Neoplasms, Prospective Studies, Quality of Life, Registries, Retrospective Studies, Cohort Studies, Prevalence, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review